Prosecution Insights
Last updated: October 02, 2026
Application No. 19/047,754

FABRIC AND HOME CARE COMPOSITION COMPRISING SURFACTANT AND A POLYESTER

Non-Final OA §112
Filed
Feb 07, 2025
Priority
Aug 08, 2022 — EU 22189169.0 +1 more
Examiner
DOUYON, LORNA M
Art Unit
Tech Center
Assignee
The Procter & Gamble Company
OA Round
1 (Non-Final)
57%
Grant Probability
Moderate
1-2
OA Rounds
1y 2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 57% of resolved cases
57%
Career Allowance Rate
565 granted / 996 resolved
-3.3% vs TC avg
Strong +72% interview lift
Without
With
+72.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
44 currently pending
Career history
1035
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
14.8%
-25.2% vs TC avg
§112
23.3%
-16.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 996 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. With respect to claims 1 and 5, a broad range or limitation together with a narrow range or limitation that falls within the broad range or limitation (in the same claim) may be considered indefinite if the resulting claim does not clearly set forth the metes and bounds of the patent protection desired. See MPEP § 2173.05(c). In the present instance, claim 1 (counting the formula as one line) recites: (a) the broad recitation “C2-C12 alkylene” in line 7, and the claim also recites “preferably C2-C6, and more preferably each independently selected from (C2H4), (C3H6)” in lines 7-8 which is the narrower statement of the range/limitation; (b) the broad recitation “C1-C20 alkyl” in line 13 and the claim also recites “preferably C1-C4 alkyl, more preferably methyl” in line 13 which is the narrower statement of the range/limitation; (c) the broad recitation “molar average number from 1 to 200” in line 14 and the claim also recites “preferably from 1 to 100, more preferably from 1 to 60” in lines 14-15 which is the narrower statement of the range/limitation. Claim 5 (counting the formula as one line) also recites: (a) the broad recitation “C2-C12 alkylene” in line 5, and the claim also recites “preferably C2-C6, and more preferably each independently selected from (C2H4), (C3H6)” in lines 5-6 which is the narrower statement of the range/limitation; (b) the broad recitation “C1-C20 alkyl” in line 9 and the claim also recites “preferably C1-C4 alkyl, more preferably methyl” in line 9 which is the narrower statement of the range/limitation. The claims are considered indefinite because there is a question or doubt as to whether the feature introduced by such narrower language is (a) merely exemplary of the remainder of the claim, and therefore not required, or (b) a required feature of the claims. Claims 2-13, being dependent from claim 1, inherit the same rejection as in claim 1 above. In addition, claim 13 is indefinite because the method does not recite positive steps in treating the surface. Allowable Subject Matter Claims 1-13 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: Carswell et al. (US 2015/0210961, already cited in IDS 11/05/2025), the closest prior art, teaches an alkaline liquid laundry detergent composition comprising at least 5 wt% non-soap surfactant and at least 0.5 wt% of a polyester according to formula (I): PNG media_image1.png 102 417 media_image1.png Greyscale wherein R1 and R2 independently of one another are X--(OC2H4)n-(OC3H6)m wherein X is C1-4 alkyl, the -(OC2H4) groups and the -(OC3H6) groups are arranged blockwise and the block consisting of the -(OC3H6) groups is bound to a COO group or are HO-(C3H6), n is based on a molar average a number of from 12 to 120, preferably 40 to 50, m is based on a molar average a number of from 1 to 10, and a is based on a molar average a number of from 4 to 9 (see abstract). Caswell, however, fails to teach, disclose or suggest a polyester with a disubstituted pyridine ring comprising at least one structural unit (A) as required in the present claim 1. Accordingly, the subject matter, as a whole, would not have been obvious to one of ordinary skill in the art. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The references are considered cumulative to or less material than those discussed above. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LORNA M DOUYON whose telephone number is (571)272-1313. The examiner can normally be reached Mondays-Fridays; 8:00 AM-4:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LORNA M DOUYON/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Feb 07, 2025
Application Filed
Sep 02, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742136
SOLID CONTROLLED RELEASE CAUSTIC DETERGENT COMPOSITIONS
2y 8m to grant Granted Sep 22, 2026
Patent 12735660
SURFACTANT BLENDS IN UNIT DOSE PACKAGES FOR IMPROVED MILDNESS
2y 10m to grant Granted Sep 15, 2026
Patent 12728085
N-ACYL AMINO ACID SURFACTANTS AND DERIVATIVES THEREOF
4y 3m to grant Granted Sep 08, 2026
Patent 12729352
METHOD FOR PRODUCING A SHEET-FORM ACTIVE INGREDIENT CARRIER, AND ACTIVE INGREDIENT CARRIER
3y 7m to grant Granted Sep 08, 2026
Patent 12716044
SOLID FAST DRAINING/DRYING RINSE AID FOR HIGH TOTAL DISSOLVED SOLID WATER CONDITIONS
2y 10m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
57%
Grant Probability
99%
With Interview (+72.1%)
2y 10m (~1y 2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 996 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month